Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC) Read more about Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)
Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development Read more about Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development
Bone Therapeutics Provides Third Quarter 2021 Business Update Read more about Bone Therapeutics Provides Third Quarter 2021 Business Update
Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB Read more about Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB
Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement Read more about Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement
Bone Therapeutics announces closing of private placement Read more about Bone Therapeutics announces closing of private placement
Bone Therapeutics: Information on the total number of voting rights and shares Read more about Bone Therapeutics: Information on the total number of voting rights and shares
Transparency notification received from Nyenburgh Holding NV Read more about Transparency notification received from Nyenburgh Holding NV
Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA Read more about Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA
Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook Read more about Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook
